Altasciences to guide development of RAP-103 peptide as chemical nerve agent therapeutic May 23, 2019
Phase II study of mirikizumab in moderate to severely active Crohn's disease meets primary endpoint May 23, 2019
New dosage and administration of Genvoya approved in Japan for pediatric HIV-1 infection May 23, 2019
Interim data from phase II study of Tavo with Keytruda in heavily pretreated metastatic TNBC May 23, 2019
Autoantibodies against LL37 and ADAMTSL5 are elevated in psoriasis and psoriatic arthritis May 23, 2019
Beta Bionics and Zealand initiate home-use trial of the iLet bionic pancreas with dasiglucagon May 23, 2019
RSS